EMERGENT INVESTORS: June 18, 2021 Filing Deadline in Class Action – Contact Lieff CabraserBusiness Wire • 04/30/21
Emergent BioSolutions, Inc. (EBS) CEO Robert Kramer on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/30/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - EBSPRNewsWire • 04/30/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Class Action Filed, Application Deadline EstablishedNewsfile Corp • 04/29/21
EMERGENT SHAREHOLDERS: June 18, 2021 Filing Deadline in Class Action – Contact Lieff CabraserBusiness Wire • 04/29/21
EBS Stock: Berger Montague Investigates Potential Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021Newsfile Corp • 04/28/21
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. - EBSNewsfile Corp • 04/27/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Emergent BioSolutions (EBS) Investors with $100k+ Losses to Contact its Attorneys Now, Securities Fraud Case Pending, Firm Investigating CEO's Insider SalesPRNewsWire • 04/27/21
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Emergent BioSolutions Inc.'s Directors and Officers for Breach of Fiduciary Duties – EBSBusiness Wire • 04/27/21
CEO of COVID-19 vaccine maker sold $10M in stock before company destroyed Johnson & Johnson dosesFox Business • 04/26/21
A vaccine maker ruined 15 million doses. Its CEO sold $11 million of stock before that was publicCNN Business • 04/26/21
Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.PRNewsWire • 04/26/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions Inc. (EBS) InvestorsBusiness Wire • 04/26/21
EBS INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - EBSPRNewsWire • 04/25/21
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. - EBSNewsfile Corp • 04/24/21
SHAREHOLDER ALERT: Robbins LLP Announces That Emergent BioSolutions Inc. (EBS) is Being Sued for Misleading ShareholdersBusiness Wire • 04/23/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions Inc. (EBS) InvestorsBusiness Wire • 04/23/21